Overview

Gender

male

Gordon Sangster joined Codexis,as CFO in 2014.Gordon Sangster joined NDC as Chief Financial Officer in October 2011. He previously served as CFO of ITC/NexusDx, a point-of-care blood diagnostic company. Prior to that, he served as CFO of Micrus Endovascular Corporation (NASDAQ: MEND), a company that developed, manufactured and marketed devices for the treatment of cerebral vascular diseases, which was acquired by Johnson and Johnson.

He also served as CFO of HemoSense, a POC blood diagnostics company, prior to its acquisition by Alere. Previously, he served as CFO of A.P.Pharma, a drug delivery company, and held various financial management positions at CooperVision and Raychem. He is a member of the Institute of Chartered Accountants in England and Wales.